<html>
<head>
<title>Title</title>
<meta http-equiv="Content-Type" content="text/html; charset=UTF-8">
</head>
<body>
Adams, M. R., R. Sears, et al. (2000). &quot;Complex Transcriptional Regulatory Mechanisms Control Expression of the E2F3 Locus.&quot; <u>Mol. Cell. Biol.</u> <b>20</b>(10): 3633-3639.<p>
Alberts, B., D. Bray, et al. (1994). <u>Molecular Biology of the Cell</u>, Garland Publishing.<p>
Altiok, S., M. Xu, et al. (1997). &quot;PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A.&quot; <u>Genes Dev.</u> <b>11</b>(15): 1987-1998.<p>
Apostolova, M. D., I. A. Ivanova, et al. (2002). &quot;Active Nuclear Import and Export Pathways Regulate E2F-5 Subcellular Localization.&quot; <u>J. Biol. Chem.</u> <b>277</b>(37): 34471-34479.<p>
Aprelikova, O., Y. Xiong, et al. (1995). &quot;Both p16 and p21 Families of Cyclin-dependent Kinase (CDK) Inhibitors Block the Phosphorylation of Cyclin-dependent Kinases by the CDK-activating Kinase.&quot; <u>J. Biol. Chem.</u> <b>270</b>(31): 18195-18197.<p>
Arakawa, Y., K. Kajino, et al. (2004). &quot;Transcription of dbpA, a Y box binding protein, is positively regulated by E2F1: implications in hepatocarcinogenesis.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>322</b>(1): 297-302.<p>
Araki, K., Y. Nakajima, et al. (2003). &quot;Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.&quot; <u>Oncogene</u> <b>22</b>(48): 7632-41.<p>
Aslanian, A., P. J. Iaquinta, et al. (2004). &quot;Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.&quot; <u>Genes Dev.</u> <b>18</b>(12): 1413-1422.<p>
Attwooll, C., E. Lazzerini Denchi, et al. (2004). &quot;The E2F family: specific functions and overlapping interests.&quot; <u>Embo J</u> <b>23</b>(24): 4709-16.<p>
Attwooll, C., S. Oddi, et al. (2005). &quot;A Novel Repressive E2F6 Complex Containing the Polycomb Group Protein, EPC1, That Interacts with EZH2 in a Proliferation-specific Manner.&quot; <u>J. Biol. Chem.</u> <b>280</b>(2): 1199-1208.<p>
Bakkenist, C. J. and M. B. Kastan (2003). &quot;DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation.&quot; <u>Nature</u> <b>421</b>(6922): 499-506.<p>
Balciunaite, E., A. Spektor, et al. (2005). &quot;Pocket Protein Complexes Are Recruited to Distinct Targets in Quiescent and Proliferating Cells.&quot; <u>Mol. Cell. Biol.</u> <b>25</b>(18): 8166-8178.<p>
Banin, S., L. Moyal, et al. (1998). &quot;Enhanced Phosphorylation of p53 by ATM in Response to DNA Damage.&quot; <u>Science</u> <b>281</b>(5383): 1674-1677.<p>
Bartek, J. and J. Lukas (2003). &quot;Chk1 and Chk2 kinases in checkpoint control and cancer.&quot; <u>Cancer Cell</u> <b>3</b>(5): 421-429.<p>
Bartkova, J., Z. Horejsi, et al. (2005). &quot;DNA damage response as a candidate anti-cancer barrier in early human tumorigenesis.&quot; <u>Nature</u> <b>434</b>(7035): 864-870.<p>
Baylin, S. and T. H. Bestor (2002). &quot;Altered methylation patterns in cancer cell genomes: cause or consequence?&quot; <u>Cancer Cell</u> <b>1</b>(4): 299-305.<p>
Bembenek, J. and H. Yu (2001). &quot;Regulation of the Anaphase-promoting Complex by the Dual Specificity Phosphatase Human Cdc14a.&quot; <u>J. Biol. Chem.</u> <b>276</b>(51): 48237-48242.<p>
Benzeno, S., F. Lu, et al. (2006). &quot;Identification of mutations that disrupt phosphorylation-dependent nuclear export of cyclin D1.&quot; <u>Oncogene</u> <b>25</b>(47): 6291-6303.<p>
Berkovich, E. and D. Ginsberg (2003). &quot;ATM is a target for positive regulation by E2F-1.&quot; <u>Oncogene</u> <b>22</b>(2): 161-7.<p>
Berteaux, N., S. Lottin, et al. (2005). &quot;H19 mRNA-like Noncoding RNA Promotes Breast Cancer Cell Proliferation through Positive Control by E2F1.&quot; <u>J. Biol. Chem.</u> <b>280</b>(33): 29625-29636.<p>
Bhattacharya, S., J. Garriga, et al. (2003). &quot;SKP2 associates with p130 and accelerates p130 ubiquitylation and degradation in human cells.&quot; <u>Oncogene</u> <b>22</b>(16): 2443-51.<p>
BioPAX_working_group. (2004). &quot;BioPAX-biological pathways exchange language. Level 1, Version 1.0 Documentation.&quot; from <A HREF="http://www.biopax.org/.">http://www.biopax.org/.</A><p>
Blais, A. and B. D. Dynlacht (2004). &quot;Hitting their targets: an emerging picture of E2F and cell cycle control.&quot; <u>Current Opinion in Genetics &amp; Development</u> <b>14</b>(5): 527-532.<p>
Blais, A., D. Monte, et al. (2002). &quot;Regulation of the Human Cyclin-dependent Kinase Inhibitor p18INK4c by the Transcription Factors E2F1 and Sp1.&quot; <u>J. Biol. Chem.</u> <b>277</b>(35): 31679-31693.<p>
Blasina, A., I. V. de Weyer, et al. (1999). &quot;A human homologue of the checkpoint kinase Cds1 directly inhibits Cdc25 phosphatase.&quot; <u>Current Biology</u> <b>9</b>(1): 1-10.<p>
Bockstaele, L., H. Kooken, et al. (2006). &quot;Regulated Activating Thr172 Phosphorylation of Cyclin-Dependent Kinase 4(CDK4): Its Relationship with Cyclins and CDK &quot;Inhibitors&quot;.&quot; <u>Mol. Cell. Biol.</u> <b>26</b>(13): 5070-5085.<p>
Booher, R. N., P. S. Holman, et al. (1997). &quot;Human Myt1 Is a Cell Cycle-regulated Kinase That Inhibits Cdc2 but Not Cdk2 Activity.&quot; <u>J. Biol. Chem.</u> <b>272</b>(35): 22300-22306.<p>
Booher, R. N., P. S. Holman, et al. (1997). &quot;Human Myt1 is a cell cycle-regulated kinase that inhibits Cdc2 but not Cdk2 activity.&quot; <u>J Biol Chem</u> <b>272</b>(35): 22300-6.<p>
Boyer Arnold, N. and M. Korc (2005). &quot;Smad7 Abrogates Transforming Growth Factor-{beta}1-mediated Growth Inhibition in COLO-357 Cells through Functional Inactivation of the Retinoblastoma Protein.&quot; <u>J. Biol. Chem.</u> <b>280</b>(23): 21858-21866.<p>
Bracken, A. P., D. Pasini, et al. (2003). &quot;EZH2 is downstream of the pRB-E2F pathway, essential for proliferation and amplified in cancer.&quot; <u>Embo J</u> <b>22</b>(20): 5323-35.<p>
Brehm, A., E. A. Miska, et al. (1998). &quot;Retinoblastoma protein recruits histone deacetylase to repress transcription.&quot; <u>Nature</u> <b>391</b>(6667): 597-601.<p>
Brown, V. D., R. A. Phillips, et al. (1999). &quot;Cumulative Effect of Phosphorylation of pRB on Regulation of E2F Activity.&quot; <u>Mol. Cell. Biol.</u> <b>19</b>(5): 3246-3256.<p>
Calbo, J., M. Parreno, et al. (2002). &quot;G1 Cyclin/Cyclin-dependent Kinase-coordinated Phosphorylation of Endogenous Pocket Proteins Differentially Regulates Their Interactions with E2F4 and E2F1 and Gene Expression.&quot; <u>J. Biol. Chem.</u> <b>277</b>(52): 50263-50274.<p>
Cam, H. and B. D. Dynlacht (2003). &quot;Emerging roles for E2F: Beyond the G1/S transition and DNA replication.&quot; <u>Cancer Cell</u> <b>3</b>(4): 311-316.<p>
Campanero, M. R., M. Armstrong, et al. (1999). &quot;Distinct Cellular Factors Regulate the c-myb Promoter through Its E2F Element.&quot; <u>Mol. Cell. Biol.</u> <b>19</b>(12): 8442-8450.<p>
Canman, C. E., D.-S. Lim, et al. (1998). &quot;Activation of the ATM Kinase by Ionizing Radiation and Phosphorylation of p53.&quot; <u>Science</u> <b>281</b>(5383): 1677-1679.<p>
Caretti, G., V. Salsi, et al. (2003). &quot;Dynamic Recruitment of NF-Y and Histone Acetyltransferases on Cell-cycle Promoters.&quot; <u>J. Biol. Chem.</u> <b>278</b>(33): 30435-30440.<p>
Castedo, M., J. L. Perfettini, et al. (2002). &quot;Cyclin-dependent kinase-1: linking apoptosis to cell cycle and mitotic catastrophe.&quot; <u>Cell Death Differ</u> <b>9</b>(12): 1287-93.<p>
Chabes, A. L., S. Bjorklund, et al. (2004). &quot;S Phase-specific Transcription of the Mouse Ribonucleotide Reductase R2 Gene Requires Both a Proximal Repressive E2F-binding Site and an Upstream Promoter Activating Region.&quot; <u>J. Biol. Chem.</u> <b>279</b>(11): 10796-10807.<p>
Chan, H. M. and N. B. La Thangue (2001). &quot;p300/CBP proteins: HATs for transcriptional bridges and scaffolds.&quot; <u>J Cell Sci</u> <b>114</b>(13): 2363-2373.<p>
Chaussepied, M. and D. Ginsberg (2004). &quot;Transcriptional Regulation of AKT Activation by E2F.&quot; <u>Molecular Cell</u> <b>16</b>(5): 831-837.<p>
Chen, C.-R., Y. Kang, et al. (2002). &quot;E2F4/5 and p107 as Smad Cofactors Linking the TGF[beta] Receptor to c-myc Repression.&quot; <u>Cell</u> <b>110</b>(1): 19-32.<p>
Chen, X. and R. Prywes (1999). &quot;Serum-Induced Expression of the cdc25A Gene by Relief of E2F-Mediated Repression.&quot; <u>Mol. Cell. Biol.</u> <b>19</b>(7): 4695-4702.<p>
Chen, Y. and Y. Sanchez (2004). &quot;Chk1 in the DNA damage response: conserved roles from yeasts to mammals.&quot; <u>DNA Repair</u> <b>3</b>(8-9): 1025-1032.<p>
Chestukhin, A., L. Litovchick, et al. (2002). &quot;Nucleocytoplasmic Shuttling of p130/RBL2: Novel Regulatory Mechanism.&quot; <u>Mol. Cell. Biol.</u> <b>22</b>(2): 453-468.<p>
Child, E. S. and D. J. Mann (2006). &quot;The intricacies of p21 phosphorylation: protein/protein interactions, subcellular localization and stability.&quot; <u>Cell Cycle</u> <b>5</b>(12): 1313-9.<p>
Chini, C. C. S. and J. Chen (2003). &quot;Human Claspin Is Required for Replication Checkpoint Control.&quot; <u>J. Biol. Chem.</u> <b>278</b>(32): 30057-30062.<p>
Choi, M., H. Lee, et al. (2002). &quot;E2F1 activates the human p53 promoter and overcomes the repressive effect of hepatitis B viral X protein (Hbx) on the p53 promoter.&quot; <u>IUBMB Life</u> <b>53</b>(6): 309-17.<p>
Christensen, J., P. Cloos, et al. (2005). &quot;Characterization of E2F8, a novel E2F-like cell-cycle regulated repressor of E2F-activated transcription.&quot; <u>Nucl. Acids Res.</u> <b>33</b>(17): 5458-5470.<p>
Classon, M. and N. Dyson (2001). &quot;p107 and p130: Versatile Proteins with Interesting Pockets.&quot; <u>Experimental Cell Research</u> <b>264</b>(1): 135-147.<p>
Claudio, P., T. Tonini, et al. (2002). &quot;The retinoblastoma family: twins or distant cousins?&quot; <u>Genome Biology</u> <b>3</b>(9): reviews3012.1 - reviews3012.9.<p>
Cobrinik, D. (2005). &quot;Pocket proteins and cell cycle control.&quot;  <b>24</b>(17): 2796-2809.<p>
Coleman, T. R., Z. Tang, et al. (1993). &quot;Negative regulation of the wee1 protein kinase by direct action of the nim1/cdr1 mitotic inducer.&quot; <u>Cell</u> <b>72</b>(6): 919-29.<p>
Connell-Crowley, L., J. W. Harper, et al. (1997). &quot;Cyclin D1/Cdk4 regulates retinoblastoma protein-mediated cell cycle arrest by site-specific phosphorylation.&quot; <u>Mol Biol Cell</u> <b>8</b>(2): 287-301.<p>
Coqueret, O. (2002). &quot;Linking cyclins to transcriptional control.&quot; <u>Gene</u> <b>299</b>(1-2): 35-55.<p>
Croxton, R., Y. Ma, et al. (2002). &quot;Direct repression of the Mcl-1 promoter by E2F1.&quot; <u>Oncogene</u> <b>21</b>(9): 1359-69.<p>
Dabrowska, M. and F. M. Sirotnak (2004). &quot;Regulation of transcription of the human MRP7 gene.: Characteristics of the basal promoter and identification of tumor-derived transcripts encoding additional 5' end heterogeneity.&quot; <u>Gene</u> <b>341</b>: 129-139.<p>
Dahiya, A., S. Wong, et al. (2001). &quot;Linking the Rb and Polycomb Pathways.&quot; <u>Molecular Cell</u> <b>8</b>(3): 557-568.<p>
Dahme, T., J. Wood, et al. (2002). &quot;Two different E2F6 proteins generated by alternative splicing and internal translation initiation.&quot; <u>European Journal of Biochemistry</u> <b>269</b>(20): 5030-5036.<p>
Darbinian, N., M. K. White, et al. (2006). &quot;Regulation of the Pur-alpha promoter by E2F-1.&quot; <u>J Cell Biochem</u> <b>99</b>(4): 1052-63.<p>
Dasgupta, P., V. Betts, et al. (2004). &quot;Direct Binding of Apoptosis Signal-regulating Kinase 1 to Retinoblastoma Protein: NOVEL LINKS BETWEEN APOPTOTIC SIGNALING AND CELL CYCLE MACHINERY.&quot; <u>J. Biol. Chem.</u> <b>279</b>(37): 38762-38769.<p>
Datta, A., A. Nag, et al. (2002). &quot;Differential Regulation of E2F1, DP1, and the E2F1/DP1 Complex by ARF.&quot; <u>Mol. Cell. Biol.</u> <b>22</b>(24): 8398-8408.<p>
Datta, A., J. Sen, et al. (2005). &quot;ARF Directly Binds DP1: Interaction with DP1 Coincides with the G1 Arrest Function of ARF.&quot; <u>Mol. Cell. Biol.</u> <b>25</b>(18): 8024-8036.<p>
Davis, J. N., M. T. McCabe, et al. (2005). &quot;Disruption of Rb/E2F Pathway Results in Increased Cyclooxygenase-2 Expression and Activity in Prostate Epithelial Cells.&quot; <u>Cancer Res</u> <b>65</b>(9): 3633-3642.<p>
de Bruin, A., B. Maiti, et al. (2003). &quot;Identification and Characterization of E2F7, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation.&quot; <u>J. Biol. Chem.</u> <b>278</b>(43): 42041-42049.<p>
DeGregori, J. (2004). &quot;The Rb network.&quot; <u>J Cell Sci</u> <b>117</b>(16): 3411-3413.<p>
DeGregori, J. and D. G. Johnson (2006). &quot;Distinct and Overlapping Roles for E2F Family Members in Transcription, Proliferation and Apoptosis.&quot; <u>Curr Mol Med</u> <b>6</b>(7): 739-48.<p>
DeGregori, J., T. Kowalik, et al. (1995). &quot;Cellular targets for activation by the E2F1 transcription factor include DNA synthesis- and G1/S-regulatory genes [published erratum appears in Mol Cell Biol 1995 Oct;15(10):5846-7].&quot; <u>Mol. Cell. Biol.</u> <b>15</b>(8): 4215-4224.<p>
Deng, C.-X. and S. G. Brodie (2000). &quot;Roles of BRCA1 and its interacting proteins.&quot; <u>BioEssays</u> <b>22</b>(8): 728-737.<p>
Desai, D., H. C. Wessling, et al. (1995). &quot;Effects of phosphorylation by CAK on cyclin binding by CDC2 and CDK2.&quot; <u>Mol. Cell. Biol.</u> <b>15</b>(1): 345-350.<p>
Deschênes, C., L. Avarez, et al. (2004). &quot;The nucleocytoplasmic shuttling of E2F4 is involved in the regulation of human intestinal epithelial cell proliferation and differentiation.&quot; <u>Journal of Cellular Physiology</u> <b>199</b>(2): 262-273.<p>
Devgan, V., C. Mammucari, et al. (2005). &quot;p21WAF1/Cip1 is a negative transcriptional regulator of Wnt4 expression downstream of Notch1 activation.&quot; <u>Genes Dev.</u> <b>19</b>(12): 1485-1495.<p>
Di Stefano, L., M. R. Jensen, et al. (2003). &quot;E2F7, a novel E2F featuring DP-independent repression of a subset of E2F-regulated genes.&quot; <u>Embo J</u> <b>22</b>(23): 6289-98.<p>
Dick, F. A. and N. Dyson (2003). &quot;pRB Contains an E2F1-Specific Binding Domain that Allows E2F1-Induced Apoptosis to Be Regulated Separately from Other E2F Activities.&quot; <u>Molecular Cell</u> <b>12</b>(3): 639-649.<p>
Diehl, J. A., F. Zindy, et al. (1997). &quot;Inhibition of cyclin D1 phosphorylation on threonine-286 prevents its rapid degradation via the ubiquitin-proteasome pathway.&quot; <u>Genes Dev</u> <b>11</b>(8): 957-72.<p>
Dimova, D. K. and N. J. Dyson (2005). &quot;The E2F transcriptional network: old acquaintances with new faces.&quot;  <b>24</b>(17): 2810-2826.<p>
Dimova, D. K., O. Stevaux, et al. (2003). &quot;Cell cycle-dependent and cell cycle-independent control of transcription by the Drosophila E2F/RB pathway.&quot; <u>Genes Dev.</u> <b>17</b>(18): 2308-2320.<p>
DuPree, E. L., S. Mazumder, et al. (2004). &quot;Genotoxic Stress Induces Expression of E2F4, Leading to Its Association with p130 in Prostate Carcinoma Cells.&quot; <u>Cancer Res</u> <b>64</b>(13): 4390-4393.<p>
Ebelt, H., N. Hufnagel, et al. (2005). &quot;Divergent Siblings: E2F2 and E2F4 but not E2F1 and E2F3 Induce DNA Synthesis in Cardiomyocytes Without Activation of Apoptosis.&quot; <u>Circ Res</u> <b>96</b>(5): 509-517.<p>
Eischen, C. M., G. Packham, et al. (2001). &quot;Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.&quot; <u>Oncogene</u> <b>20</b>(48): 6983-93.<p>
Fajas, L., R. L. Landsberg, et al. (2002). &quot;E2Fs Regulate Adipocyte Differentiation.&quot; <u>Developmental Cell</u> <b>3</b>(1): 39-49.<p>
Fang, W., T. Mori, et al. (2002). &quot;Regulation of PML-dependent transcriptional repression by pRB and low penetrance pRB mutants.&quot; <u>Oncogene</u> <b>21</b>(36): 5557-65.<p>
Farkas, T., K. Hansen, et al. (2002). &quot;Distinct Phosphorylation Events Regulate p130- and p107-mediated Repression of E2F-4.&quot; <u>J. Biol. Chem.</u> <b>277</b>(30): 26741-26752.<p>
Fernandez de Mattos, S., E. W. Lam, et al. (2002). &quot;An E2F-binding site mediates the activation of the proliferative isoform of 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase by phosphatidylinositol 3-kinase.&quot; <u>Biochem J</u> <b>368</b>(Pt 1): 283-91.<p>
Ferreira, R., I. Naguibneva, et al. (2001). &quot;Cell cycle-dependent recruitment of HDAC-1 correlates with deacetylation of histone H4 on an Rb-E2F target promoter.&quot; <u>EMBO Rep</u> <b>2</b>(9): 794-9.<p>
Ferreira, R., I. Naguibneva, et al. (2001). &quot;The Rb/chromatin connection and epigenetic control: opinion.&quot; <u>Oncogene</u> <b>20</b>(24): 3128-33.<p>
Fogal, V., N. N. Kartasheva, et al. (2005). &quot;ASPP1 and ASPP2 are new transcriptional targets of E2F.&quot; <u>Cell Death Differ</u> <b>12</b>(4): 369-376.<p>
Foray, N., D. Marot, et al. (2003). &quot;A subset of ATM- and ATR-dependent phosphorylation events requires the BRCA1 protein.&quot; <u>Embo J</u> <b>22</b>(11): 2860-71.<p>
Fortin, A., J. G. MacLaurin, et al. (2004). &quot;The Proapoptotic Gene SIVA Is a Direct Transcriptional Target for the Tumor Suppressors p53 and E2F1.&quot; <u>J. Biol. Chem.</u> <b>279</b>(27): 28706-28714.<p>
Fox, E. J. and S. C. Wright (2003). &quot;The transcriptional repressor gene Mad3 is a novel target for regulation by E2F1.&quot; <u>Biochem J</u> <b>370</b>(Pt 1): 307-13.<p>
Freedman, D. A. and A. J. Levine (1998). &quot;Nuclear Export Is Required for Degradation of Endogenous p53 by MDM2 and Human Papillomavirus E6.&quot; <u>Mol. Cell. Biol.</u> <b>18</b>(12): 7288-7293.<p>
Friend, S., R. Bernards, et al. (1986). &quot;A human DNA segment with properties of the gene that predisposes to retinoblastoma and osteosarcoma.&quot; <u>Nature</u> <b>323</b>(6089): 643-6.<p>
Frolov, M. V. and N. J. Dyson (2004). &quot;Molecular mechanisms of E2F-dependent activation and pRB-mediated repression.&quot; <u>J Cell Sci</u> <b>117</b>(11): 2173-2181.<p>
Fuchs, S., V. Adler, et al. (1998). &quot;Mdm2 association with p53 targets its ubiquitination.&quot; <u>Oncogene</u> <b>17</b>(19): 2543-7.<p>
Funahashi, A., N. Tanimura, et al. (2003). &quot;CellDesigner: a process diagram editor for gene-regulatory and biochemical networks.&quot; 159-162.<p>
Fung, T., C. Yam, et al. (2005 ). &quot;The N-terminal regulatory domain of cyclin A contains redundant ubiquitination targeting sequences and acceptor sites.&quot; <u>Cell Cycle</u> <b>4</b>(10): 1411-20.<p>
Fung, T. K. and R. Y. C. Poon (2005). &quot;A roller coaster ride with the mitotic cyclins.&quot; <u>Seminars in Cell &amp; Developmental Biology</u> <b>16</b>(3): 335-342.<p>
Funke-Kaiser, H., F. Reichenberger, et al. (2003). &quot;Differential binding of transcription factor E2F-2 to the endothelin-converting enzyme-1b promoter affects blood pressure regulation.&quot; <u>Hum Mol Genet</u> <b>12</b>(4): 423-33.<p>
Funke-Kaiser, H., A. Thomas, et al. (2003). &quot;Regulation of the major isoform of human endothelin-converting enzyme-1 by a strong housekeeping promoter modulated by polymorphic microsatellites.&quot; <u>J Hypertens</u> <b>21</b>(11): 2111-24.<p>
Furukawa, Y., N. Nishimura, et al. (2002). &quot;Apaf-1 Is a Mediator of E2F-1-induced Apoptosis.&quot; <u>J. Biol. Chem.</u> <b>277</b>(42): 39760-39768.<p>
Futreal, P. A., L. Coin, et al. (2004). &quot;A census of human cancer genes.&quot; <u>Nature Reviews Cancer</u> <b>4</b>(3): 177-183.<p>
Gagneur, J. and S. Klamt (2004). &quot;Computation of elementary modes: a unifying framework and the new binary approach.&quot; <u>BMC Bioinformatics</u> <b>5</b>(1): 175.<p>
Gagneur, J., R. Krause, et al. (2004). &quot;Modular decomposition of protein-protein interaction networks.&quot; <u>Genome Biology</u> <b>5</b>(8): R57.<p>
Gagrica, S., S. Hauser, et al. (2004 ). &quot;Inhibition of oncogenic transformation by mammalian Lin-9, a pRB-associated protein.&quot; <u>EMBO J.</u> <b>23</b>(23): 4627-38.<p>
Galbiati, L., R. Mendoza-Maldonado, et al. (2005). &quot;Regulation of E2F-1 after DNA damage by p300-mediated acetylation and ubiquitination.&quot; <u>Cell Cycle</u> <b>4</b>(7): 930-9.<p>
Gao, G., A. P. Bracken, et al. (2003). &quot;NPAT Expression Is Regulated by E2F and Is Essential for Cell Cycle Progression.&quot; <u>Mol. Cell. Biol.</u> <b>23</b>(8): 2821-2833.<p>
Gartel, A. L., E. Goufman, et al. (1998). &quot;Activation and repression of p21(WAF1/CIP1) transcription by RB binding proteins.&quot; <u>Oncogene</u> <b>17</b>(26): 3463-9.<p>
Gaubatz, S., J. A. Lees, et al. (2001). &quot;E2F4 Is Exported from the Nucleus in a CRM1-Dependent Manner.&quot; <u>Mol. Cell. Biol.</u> <b>21</b>(4): 1384-1392.<p>
Gaubatz, S., G. J. Lindeman, et al. (2000). &quot;E2F4 and E2F5 Play an Essential Role in Pocket Protein-Mediated G1 Control.&quot; <u>Molecular Cell</u> <b>6</b>(3): 729-735.<p>
Genovese, C., D. Trani, et al. (2006). &quot;Cell cycle control and beyond: emerging roles for the retinoblastoma gene family.&quot; <u>Oncogene</u> <b>25</b>(38): 5201-5209.<p>
Gery, S., A. F. Gombart, et al. (2004). &quot;C/EBP{epsilon} interacts with retinoblastoma and E2F1 during granulopoiesis.&quot; <u>Blood</u> <b>103</b>(3): 828-835.<p>
Giacinti, C. and A. Giordano (2006). &quot;RB and cell cycle progression.&quot; <u>Oncogene</u> <b>25</b>(38): 5220-5227.<p>
Giangrande, P. H., T. C. Hallstrom, et al. (2003). &quot;Identification of E-Box Factor TFE3 as a Functional Partner for the E2F3 Transcription Factor.&quot; <u>Mol. Cell. Biol.</u> <b>23</b>(11): 3707-3720.<p>
Giangrande, P. H., W. Zhu, et al. (2004). &quot;Combinatorial gene control involving E2F and E Box family members.&quot; <u>Embo J</u> <b>23</b>(6): 1336-47.<p>
Giangrande, P. H., W. Zhu, et al. (2004). &quot;A role for E2F6 in distinguishing G1/S- and G2/M-specific transcription.&quot; <u>Genes Dev.</u> <b>18</b>(23): 2941-2951.<p>
Ginsberg, D. (2004). &quot;E2F3--A Novel Repressor of the ARF/p53 Pathway.&quot; <u>Developmental Cell</u> <b>6</b>(6): 742-743.<p>
Gomez-Manzano, C., P. Mitlianga, et al. (2001). &quot;Transfer of E2F-1 to Human Glioma Cells Results in Transcriptional Up-Regulation of Bcl-2.&quot; <u>Cancer Res</u> <b>61</b>(18): 6693-6697.<p>
Goto, Y., R. Hayashi, et al. (2006). &quot;JPO1/CDCA7, a novel transcription factor E2F1-induced protein, possesses intrinsic transcriptional regulator activity.&quot; <u>Biochim Biophys Acta</u> <b>1759</b>(1-2): 60-8.<p>
Grafstrom, R. H., W. Pan, et al. (1999). &quot;Defining the substrate specificity of cdk4 kinase–cyclin D1 complex.&quot; <u>Carcinogenesis</u> <b>20</b>(2): 193-198.<p>
Graves, P., C. Lovly, et al. (2001). &quot;Localization of human Cdc25C is regulated both by nuclear export and 14-3-3 protein binding.&quot; <u>Oncogene</u> <b>20</b>(15): 1839-51.<p>
Guan, K., C. Jenkins, et al. (1994). &quot;Growth suppression by p18, a p16INK4/MTS1- and p14INK4B/MTS2-related CDK6 inhibitor, correlates with wild-type pRb function.&quot; <u>Genes Dev.  </u><b>8</b>: 2939-52.<p>
Guan, K., C. Jenkins, et al. (1996). &quot;Isolation and characterization of p19INK4d, a p16-related inhibitor specific to CDK6 and CDK4.&quot; <u>Mol Biol Cell</u> <b>7</b>(1): 57-70.<p>
Gunawardena, R. W., H. Siddiqui, et al. (2004). &quot;Hierarchical Requirement of SWI/SNF in Retinoblastoma Tumor Suppressor-mediated Repression of Plk1.&quot; <u>J. Biol. Chem.</u> <b>279</b>(28): 29278-29285.<p>
Hagting, A., M. Jackman, et al. (1999). &quot;Translocation of cyclin B1 to the nucleus at prophase requires a phosphorylation-dependent nuclear import signal.&quot; <u>Current Biology</u> <b>9</b>(13): 680-689.<p>
Hagting, A., C. Karlsson, et al. (1998). &quot;MPF localization is controlled by nuclear export.&quot; <u>Embo J</u> <b>17</b>(14): 4127-38.<p>
Hannon, G. J. and D. Beach (1994). &quot;pl5INK4B is a potentia| effector of TGF-[beta]-induced cell cycle arrest.&quot; <u>Nature</u> <b>371</b>(6494): 257-261.<p>
Hansen, K., T. Farkas, et al. (2001). &quot;Phosphorylation-dependent and -independent functions of p130 cooperate to evoke a sustained G1 block.&quot; <u>EMBO J.</u> <b>20</b>(3): 422-32.<p>
Harris, S. L. and A. J. Levine (2005). &quot;The p53 pathway: positive and negative feedback loops.&quot; <u>Oncogene</u> <b>24</b>(17): 2899-2908.<p>
Hayashi, R., Y. Goto, et al. (2006). &quot;Comparative genomics on MCM8 orthologous genes reveals the transcriptional regulation by transcription factor E2F.&quot; <u>Gene</u> <b>367</b>: 126-34.<p>
Hayashi, R., Y. Goto, et al. (2006). &quot;CDCA4 is an E2F transcription factor family-induced nuclear factor that regulates E2F-dependent transcriptional activation and cell proliferation.&quot; <u>J Biol Chem</u> <b>281</b>(47): 35633-48.<p>
He, Y. and W. D. Cress (2002). &quot;E2F-3B Is a Physiological Target of Cyclin A.&quot; <u>J. Biol. Chem.</u> <b>277</b>(26): 23493-23499.<p>
Heald, R., M. McLoughlin, et al. (1993). &quot;Human wee1 maintains mitotic timing by protecting the nucleus from cytoplasmically activated cdc2 kinase.&quot; <u>Cell</u> <b>74</b>(3): 463-474.<p>
Hengst, L., U. Gopfert, et al. (1998). &quot;Complete inhibition of Cdk/cyclin by one molecule of p21Cip1.&quot; <u>Genes Dev.</u> <b>12</b>(24): 3882-3888.<p>
Hershko, T., M. Chaussepied, et al. (2005). &quot;Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F.&quot; <u>Cell Death Differ</u> <b>12</b>(4): 377-383.<p>
Hershko, T. and D. Ginsberg (2004). &quot;Up-regulation of Bcl-2 Homology 3 (BH3)-only Proteins by E2F1 Mediates Apoptosis.&quot; <u>J. Biol. Chem.</u> <b>279</b>(10): 8627-8634.<p>
Hitchens, M. R. and P. D. Robbins (2003). &quot;The role of the transcription factor DP in apoptosis.&quot; <u>Apoptosis</u> <b>8</b>(5): 461-468.<p>
Hlaing, M., P. Spitz, et al. (2004). &quot;E2F-1 Regulates the Expression of a Subset of Target Genes during Skeletal Myoblast Hypertrophy.&quot; <u>J. Biol. Chem.</u> <b>279</b>(42): 43625-43633.<p>
Hofmann, F. and D. Livingston (1996). &quot;Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.&quot; <u>Genes Dev.</u> <b>10</b>(7): 851-61.<p>
Honda, R., Y. Ohba, et al. (1993). &quot;Dephosphorylation of human p34cdc2 kinase on both Thr-14 and Tyr-15 by human cdc25B phosphatase.&quot; <u>FEBS Letters</u> <b>318</b>(3): 331-334.<p>
Honda, R., H. Tanaka, et al. (1997). &quot;Oncoprotein MDM2 is a ubiquitin ligase E3 for tumor suppressor p53.&quot; <u>FEBS Letters</u> <b>420</b>(1): 25-27.<p>
Huang, D., M. Jokela, et al. (2001). &quot;E2F mediates induction of the Sp1-controlled promoter of the human DNA polymerase {{epsilon}} B-subunit gene POLE2.&quot; <u>Nucl. Acids Res.</u> <b>29</b>(13): 2810-2821.<p>
Huang, H., O. Zegarra-Moro, et al. (2004). &quot;Androgens repress Bcl-2 expression via activation of the retinoblastoma (RB) protein in prostate cancer cells.&quot; <u>Oncogene</u> <b>23</b>(12): 2161-76.<p>
Hucka, M., A. Finney, et al. (2003). &quot;The systems biology markup language (SBML): a medium for representation and exchange of biochemical network models.&quot; <u>Bioinformatics</u> <b>19</b>(4): 524-531.<p>
Hughes, T. A. and H. J. M. Brady (2005). &quot;Cross-talk between pRb/E2F and Wnt/[beta]-catenin pathways: E2F1 induces axin2 leading to repression of Wnt signalling and to increased cell death.&quot; <u>Experimental Cell Research</u> <b>303</b>(1): 32-46.<p>
Hughes, T. A. and H. J. M. Brady (2005). &quot;E2F1 up-regulates the expression of the tumour suppressor axin2 both by activation of transcription and by mRNA stabilisation.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>329</b>(4): 1267-1274.<p>
Humbert, P. O., R. Verona, et al. (2000). &quot;E2f3 is critical for normal cellular proliferation.&quot; <u>Genes Dev.</u> <b>14</b>(6): 690-703.<p>
Ianari, A., R. Gallo, et al. (2004). &quot;Specific Role for p300/CREB-binding Protein-associated Factor Activity in E2F1 Stabilization in Response to DNA Damage.&quot; <u>J. Biol. Chem.</u> <b>279</b>(29): 30830-30835.<p>
Ingenuity_Systems. &quot;www.ingenuity.com.&quot;<p>
Irwin, M., M. C. Marin, et al. (2000). &quot;Role for the p53 homologue p73 in E2F-1-induced apoptosis.&quot; <u>Nature</u> <b>407</b>(6804): 645-648.<p>
Ishida, H., Y. Masuhiro, et al. (2005). &quot;Identification and Characterization of Novel Isoforms of Human DP-1: DP-1{alpha} REGULATES THE TRANSCRIPTIONAL ACTIVITY OF E2F1 AS WELL AS CELL CYCLE PROGRESSION IN A DOMINANT-NEGATIVE MANNER.&quot; <u>J. Biol. Chem.</u> <b>280</b>(26): 24642-24648.<p>
Ishii, H., K. Mimori, et al. (2004). &quot;Effect of exogenous E2F-1 on the expression of common chromosome fragile site genes, FHIT and WWOX.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>316</b>(4): 1088-1093.<p>
Iwanaga, R., H. Komori, et al. (2006). &quot;Identification of novel E2F1 target genes regulated in cell cycle-dependent and independent manners.&quot; <u>Oncogene</u> <b>25</b>(12): 1786-98.<p>
Jackman, M., C. Lindon, et al. (2003). &quot;Active cyclin B1-Cdk1 first appears on centrosomes in prophase.&quot; <u>Nat Cell Biol</u> <b>5</b>(2): 143-148.<p>
Jacobs, J. J. L. and M. van Lohuizen (2002). &quot;Polycomb repression: from cellular memory to cellular proliferation and cancer.&quot; <u>Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</u> <b>1602</b>(2): 151-161.<p>
Jhanwar-Uniyal, M. (2003). &quot;BRCA1 in cancer, cell cycle and genomic stability.&quot; <u>Front Biosci.</u> <b>8</b>: s1107-17.<p>
Jiang, S. X., M. Sheldrick, et al. (2007). &quot;Neuropilin-1 is a direct target of the transcription factor E2F1 during cerebral ischemia-induced neuronal death in vivo.&quot; <u>Mol Cell Biol</u> <b>27</b>(5): 1696-705.<p>
Jiang, Y., H. I. Saavedra, et al. (2004). &quot;Aberrant Regulation of Survivin by the RB/E2F Family of Proteins.&quot; <u>J. Biol. Chem.</u> <b>279</b>(39): 40511-40520.<p>
Johnson, D. and R. Schneider-Broussard (1998). &quot;Role of E2F in cell cycle control and cancer.&quot; <u>Front Biosci.</u> <b>3</b>: d447-8.<p>
Joshi-Tope, G., M. Gillespie, et al. (2005). &quot;Reactome: a knowledgebase of biological pathways.&quot; <u>Nucl. Acids Res.</u> <b>33</b>(suppl_1): D428-432.<p>
Kaelin, W. J. (2003). &quot; E2F1 as a target: promoter-driven suicide and small molecule modulators.&quot; <u>Cancer Biol Ther.</u> <b>2</b>(4 Suppl 1): S48-54.<p>
Kalma, Y., L. Marash, et al. (2001). &quot;Expression analysis using DNA microarrays demonstrates that E2F-1 up-regulates expression of DNA replication genes including replication protein A2.&quot; <u>Oncogene</u> <b>20</b>(11): 1379-87.<p>
Kamb, A. (1994). &quot;A cell cycle regulator potentially involved in genesis of many tumor types.&quot; <u>Science</u> <b>264</b>: 436-440.<p>
Kanehisa, M. and S. Goto (2000). &quot;KEGG: Kyoto Encyclopedia of Genes and Genomes.&quot; <u>Nucl. Acids Res.</u> <b>28</b>(1): 27-30.<p>
Katich, S., K. Zerfass-Thome, et al. (2001). &quot;Regulation of the Cdc25A gene by the human papillomavirus Type 16 E7 oncogene.&quot; <u>Oncogene</u> <b>20</b>(5): 543-50.<p>
Kaye, F. (2002 ). &quot; RB and cyclin dependent kinase pathways: defining a distinction between RB and p16 loss in lung cancer.&quot; <u>Oncogene</u> <b>21</b>(45): 6908-14.<p>
Khanna, K. K., K. E. Keating, et al. (1998). &quot;ATM associates with and phosphorylates p53: mapping the region of interaction.&quot; <u>Nat Genet</u> <b>20</b>(4): 398-400.<p>
Kherrouche, Z., A. Blais, et al. (2006). &quot;ASK-1 (apoptosis signal-regulating kinase 1) is a direct E2F target gene.&quot; <u>Biochem J</u> <b>396</b>(3): 547-56.<p>
Kikuchi, H., Y. Takami, et al. (2005). &quot;GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes.&quot; <u>Gene</u> <b>347</b>(1): 83-97.<p>
Kim, J., A. A. Bhinge, et al. (2005). &quot;Mapping DNA-protein interactions in large genomes by sequence tag analysis of genomic enrichment.&quot; <u>Nat Meth</u> <b>2</b>(1): 47-53.<p>
Kimura, M., C. Uchida, et al. (2004). &quot;Cell cycle-dependent regulation of the human aurora B promoter.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>316</b>(3): 930-936.<p>
Kishore, R., C. Luedemann, et al. (2003). &quot;Tumor Necrosis Factor-Mediated E2F1 Suppression in Endothelial Cells: Differential Requirement of c-Jun N-Terminal Kinase and p38 Mitogen-Activated Protein Kinase Signal Transduction Pathways.&quot; <u>Circ Res</u> <b>93</b>(10): 932-940.<p>
Kitano, H., A. Funahashi, et al. (2005). &quot;Using process diagrams for the graphical representation of biological networks.&quot; <u>Nat Biotech</u> <b>23</b>(8): 961-966.<p>
Klamt, S., J. Saez-Rodriguez, et al. (2006). &quot;A methodology for the structural and functional analysis of signaling and regulatory networks.&quot; <u>BMC Bioinformatics</u> <b>7</b>(1): 56.<p>
Klipp, E., W. Liebermeister, et al. (2007). &quot;Systems biology standards - the community speaks.&quot; <u>Nat Biotech</u> <b>25</b>(4): 390-391.<p>
Knudsen, E. S. and J. Y. Wang (1997). &quot;Dual mechanisms for the inhibition of E2F binding to RB by cyclin- dependent kinase-mediated RB phosphorylation.&quot; <u>Mol. Cell. Biol.</u> <b>17</b>(10): 5771-5783.<p>
Knudson, A. J. (1971). &quot;Mutation and cancer: statistical study of retinoblastoma.&quot; <u>Proc Natl Acad Sci U S A</u> <b>68</b>(4).<p>
Kohn, K. W. (1999). &quot;Molecular Interaction Map of the Mammalian Cell Cycle Control and DNA Repair Systems.&quot; <u>Mol. Biol. Cell</u> <b>10</b>(8): 2703-2734.<p>
Koziczak, M., H. Muller, et al. (2001). &quot;E2F1-mediated transcriptional inhibition of the plasminogen activator inhibitor type 1 gene.&quot; <u>European Journal of Biochemistry</u> <b>268</b>(18): 4969-4978.<p>
Krull, M., S. Pistor, et al. (2006). &quot;TRANSPATH: an information resource for storing and visualizing signaling pathways and their pathological aberrations.&quot; <u>Nucl. Acids Res.</u> <b>34</b>(suppl_1): D546-551.<p>
Krummenacker, M., S. Paley, et al. (2005). &quot;Querying and computing with BioCyc databases.&quot; <u>Bioinformatics</u> <b>21</b>(16): 3454-3455.<p>
Kumagai, A. and W. G. Dunphy (2000). &quot;Claspin, a Novel Protein Required for the Activation of Chk1 during a DNA Replication Checkpoint Response in Xenopus Egg Extracts.&quot; <u>Molecular Cell</u> <b>6</b>(4): 839-849.<p>
Kuwako, K.-i., H. Taniura, et al. (2004). &quot;Necdin-related MAGE Proteins Differentially Interact with the E2F1 Transcription Factor and the p75 Neurotrophin Receptor.&quot; <u>J. Biol. Chem.</u> <b>279</b>(3): 1703-1712.<p>
Kyrylenko, S., P. Korhonen, et al. (2000). &quot;Expression of Transcriptional Repressor Proteins mSin3A and 3B during Aging and Replicative Senescence.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>275</b>(2): 455-459.<p>
LaBaer, J., M. Garrett, et al. (1997). &quot;New functional activities for the p21 family of CDK inhibitors.&quot; <u>Genes Dev.</u> <b>11</b>(7): 847-62.<p>
Lai, A., B. K. Kennedy, et al. (2001). &quot;RBP1 Recruits the mSIN3-Histone Deacetylase Complex to the Pocket of Retinoblastoma Tumor Suppressor Family Proteins Found in Limited Discrete Regions of the Nucleus at Growth Arrest.&quot; <u>Mol. Cell. Biol.</u> <b>21</b>(8): 2918-2932.<p>
Lang, S. E., S. B. McMahon, et al. (2001). &quot;E2F Transcriptional Activation Requires TRRAP and GCN5 Cofactors.&quot; <u>J. Biol. Chem.</u> <b>276</b>(35): 32627-32634.<p>
Larsen, C. (2004). &quot;[pRB, p53, p16INK4a, senescence and malignant transformation].&quot; <u>Bull Cancer</u> <b>91</b>(5): 399-402.<p>
Latres, E., M. Malumbres, et al. (2000). &quot;Limited overlapping roles of P15(INK4b) and P18(INK4c) cell cycle inhibitors in proliferation and tumorigenesis.&quot; <u>EMBO J.</u> <b>19</b>(13): 3496-506.<p>
Lavrrar, J. L. and P. J. Farnham (2004). &quot;The Use of Transient Chromatin Immunoprecipitation Assays to Test Models for E2F1-specific Transcriptional Activation.&quot; <u>J. Biol. Chem.</u> <b>279</b>(44): 46343-46349.<p>
Le Novere, N., A. Finney, et al. (2005). &quot;Minimum information requested in the annotation of biochemical models (MIRIAM).&quot; <u>Nat Biotech</u> <b>23</b>(12): 1509-1515.<p>
Lee, J. H., B. Xu, et al. (2003). &quot;Distinct Functions of Nijmegen Breakage Syndrome in Ataxia Telangiectasia Mutated-Dependent Responses to DNA Damage.&quot; <u>Mol Cancer Res</u> <b>1</b>(9): 674-681.<p>
Legewie, S., Bl, et al. (2006). &quot;Mathematical Modeling Identifies Inhibitors of Apoptosis as Mediators of Positive Feedback and Bistability.&quot; <u>PLoS Computational Biology</u> <b>2</b>(9): e120.<p>
Leone, G., F. Nuckolls, et al. (2000). &quot;Identification of a Novel E2F3 Product Suggests a Mechanism for Determining Specificity of Repression by Rb Proteins.&quot; <u>Mol. Cell. Biol.</u> <b>20</b>(10): 3626-3632.<p>
Li, Q., W.-M. Dashwood, et al. (2004). &quot;Cloning of the rat [beta]-catenin gene (Ctnnb1) promoter and its functional analysis compared with the Catnb and CTNNB1 promoters.&quot; <u>Genomics</u> <b>83</b>(2): 231-242.<p>
Li, Z., J. Stanelle, et al. (2005). &quot;Selection of novel mediators of E2F1-induced apoptosis through retroviral expression of an antisense cDNA library.&quot; <u>Nucl. Acids Res.</u> <b>33</b>(9): 2813-2821.<p>
Liang, J. and J. Slingerland (2003). &quot;Multiple roles of the PI3K/PKB (Akt) pathway in cell cycle progression.&quot; <u>Cell Cycle</u> <b>2</b>(4): 339-45.<p>
Lin, W.-C., F.-T. Lin, et al. (2001). &quot;Selective induction of E2F1 in response to DNA damage, mediated by ATM-dependent phosphorylation.&quot; <u>Genes Dev.</u> <b>15</b>(14): 1833-1844.<p>
Lindqvist, A., H. Kallstrom, et al. (2004). &quot;Characterisation of Cdc25B localisation and nuclear export during the cell cycle and in response to stress.&quot; <u>J Cell Sci</u> <b>117</b>(21): 4979-4990.<p>
Litovchick, L., A. Chestukhin, et al. (2004). &quot;Glycogen Synthase Kinase 3 Phosphorylates RBL2/p130 during Quiescence.&quot; <u>Mol. Cell. Biol.</u> <b>24</b>(20): 8970-8980.<p>
Liu, D. X., N. Nath, et al. (2005). &quot;Regulation of neuron survival and death by p130 and associated chromatin modifiers.&quot; <u>Genes Dev.</u> <b>19</b>(6): 719-732.<p>
Liu, F. and W.-H. Lee (2006). &quot;CtIP Activates Its Own and Cyclin D1 Promoters via the E2F/RB Pathway during G1/S Progression.&quot; <u>Mol. Cell. Biol.</u> <b>26</b>(8): 3124-3134.<p>
Liu, F., C. Rothblum-Oviatt, et al. (1999). &quot;Overproduction of Human Myt1 Kinase Induces a G2 Cell Cycle Delay by Interfering with the Intracellular Trafficking of Cdc2-Cyclin B1 Complexes.&quot; <u>Mol. Cell. Biol.</u> <b>19</b>(7): 5113-5123.<p>
Liu, F., J. J. Stanton, et al. (1997). &quot;The human Myt1 kinase preferentially phosphorylates Cdc2 on threonine 14 and localizes to the endoplasmic reticulum and Golgi complex.&quot; <u>Mol. Cell. Biol.</u> <b>17</b>(2): 571-583.<p>
Liu, H., C. Peng, et al. (2006). &quot;Cloning and characterization of the BRD7 gene promoter.&quot; <u>DNA Cell Biol</u> <b>25</b>(6): 346-58.<p>
Liu, K., F.-T. Lin, et al. (2003). &quot;Regulation of E2F1 by BRCT Domain-Containing Protein TopBP1.&quot; <u>Mol. Cell. Biol.</u> <b>23</b>(9): 3287-3304.<p>
Liu, K., Y. Luo, et al. (2004). &quot;TopBP1 recruits Brg1/Brm to repress E2F1-induced apoptosis, a novel pRb-independent and E2F1-specific control for cell survival.&quot; <u>Genes Dev.</u> <b>18</b>(6): 673-686.<p>
Liu, N., F. C. Lucibello, et al. (1996). &quot;Cell cycle-regulated repression of B-myb transcription: cooperation of an E2F site with a contiguous corepressor element.&quot; <u>Nucl. Acids Res.</u> <b>24</b>(15): 2905-2910.<p>
Liu, Q., S. Guntuku, et al. (2000). &quot;Chk1 is an essential kinase that is regulated by Atr and required for the G2/M DNA damage checkpoint.&quot; <u>Genes Dev.</u> <b>14</b>(12): 1448-1459.<p>
Logan, N., L. Delavaine, et al. (2004). &quot;E2F-7: a distinctive E2F family member with an unusual organization of DNA-binding domains.&quot; <u>Oncogene</u> <b>23</b>(30): 5138-50.<p>
Logan, N., A. Graham, et al. (2005). &quot;E2F-8: an E2F family member with a similar organization of DNA-binding domains to E2F-7.&quot; <u>Oncogene</u> <b>24</b>(31): 5000-5004.<p>
Lu, Z., R. Z. Luo, et al. (2005). &quot;E2F-HDAC complexes negatively regulate the tumor suppressor gene ARHI in breast cancer.&quot; <u>Oncogene</u> <b>25</b>(2): 230-239.<p>
Luciakova, K., P. Barath, et al. (2000). &quot;Activity of the human cytochrome c1 promoter is modulated by E2F.&quot; <u>Biochem J</u> <b>351</b>(Pt 1): 251-6.<p>
Ludlow, J. W., C. L. Glendening, et al. (1993). &quot;Specific enzymatic dephosphorylation of the retinoblastoma protein.&quot; <u>Mol. Cell. Biol.</u> <b>13</b>(1): 367-372.<p>
Lukas, C., C. S. Sorensen, et al. (1999). &quot;Accumulation of cyclin B1 requires E2F and cyclin-A-dependent rearrangement of the anaphase-promoting complex.&quot; <u>Nature</u> <b>401</b>(6755): 815-818.<p>
Lukas, J. and J. Bartek (2004). &quot;Cell division: the heart of the cycle.&quot; <u>Nature</u> <b>432</b>(7017): 564-7.<p>
Lund, A. H. and M. van Lohuizen (2004). &quot;Polycomb complexes and silencing mechanisms.&quot; <u>Current Opinion in Cell Biology</u> <b>16</b>(3): 239-246.<p>
Lyons, T. E., M. Salih, et al. (2006). &quot;Activating E2Fs mediate transcriptional regulation of human E2F6 repressor.&quot; <u>Am J Physiol Cell Physiol</u> <b>290</b>(1): C189-199.<p>
Ma, Y., R. Croxton, et al. (2002). &quot;Identification of Novel E2F1-Regulated Genes by Microarray.&quot; <u>Archives of Biochemistry and Biophysics</u> <b>399</b>(2): 212-224.<p>
Ma, Y., J. Yuan, et al. (2003). &quot;Regulation of the Cyclin D3 Promoter by E2F1.&quot; <u>J. Biol. Chem.</u> <b>278</b>(19): 16770-16776.<p>
Macaluso, M., C. Cinti, et al. (2003). &quot;pRb2/p130-E2F4/5-HDAC1-SUV39H1-p300 and pRb2/p130-E2F4/5-HDAC1-SUV39H1-DNMT1 multimolecular complexes mediate the transcription of estrogen receptor-alpha in breast cancer.&quot; <u>Oncogene</u> <b>22</b>(23): 3511-7.<p>
Magae, J., C. L. Wu, et al. (1996). &quot;Nuclear localization of DP and E2F transcription factors by heterodimeric partners and retinoblastoma protein family members.&quot; <u>J Cell Sci</u> <b>109</b>(7): 1717-1726.<p>
Magnaghi-Jaulin, L., R. Groisman, et al. (1998). &quot;Retinoblastoma protein represses transcription by recruiting a histone deacetylase.&quot; <u>Nature</u> <b>391</b>(6667): 601-605.<p>
Mailand, N., J. Falck, et al. (2000). &quot;Rapid Destruction of Human Cdc25A in Response to DNA Damage.&quot; <u>Science</u> <b>288</b>(5470): 1425-1429.<p>
Mailand, N., A. Podtelejnikov, et al. (2002). &quot;Regulation of G(2)/M events by Cdc25A through phosphorylation-dependent modulation of its stability.&quot; <u>EMBO J. </u><b>21</b>(21): 5911-20.<p>
Maiti, B., J. Li, et al. (2005). &quot;Cloning and Characterization of Mouse E2F8, a Novel Mammalian E2F Family Member Capable of Blocking Cellular Proliferation.&quot; <u>J. Biol. Chem.</u> <b>280</b>(18): 18211-18220.<p>
Malumbres, M., S. Ortega, et al. (2000). &quot;Genetic analysis of mammalian cyclin-dependent kinases and their inhibitors.&quot;<u> Biol Chem.</u> <b>381</b>(9-10): 827-38.<p>
Marabese, M., F. Vikhanskaya, et al. (2003). &quot;DNA damage induces transcriptional activation of p73 by removing C-EBP{alpha} repression on E2F1.&quot; <u>Nucl. Acids Res.</u> <b>31</b>(22): 6624-6632.<p>
Markey, M. P., S. P. Angus, et al. (2002). &quot;Unbiased Analysis of RB-mediated Transcriptional Repression Identifies Novel Targets and Distinctions from E2F Action.&quot; <u>Cancer Res</u> <b>62</b>(22): 6587-6597.<p>
Martelli, F., T. Hamilton, et al. (2001). &quot;p19ARF targets certain E2F species for degradation.&quot; <u>PNAS</u> <b>98</b>(8): 4455-4460.<p>
Marzio, G., C. Wagener, et al. (2000). &quot;E2F Family Members Are Differentially Regulated by Reversible Acetylation.&quot; <u>J. Biol. Chem.</u> <b>275</b>(15): 10887-10892.<p>
Matsuoka, S., M. Huang, et al. (1998). &quot;Linkage of ATM to Cell Cycle Regulation by the Chk2 Protein Kinase.&quot; <u>Science</u> <b>282</b>(5395): 1893-1897.<p>
Matsuoka, S., G. Rotman, et al. (2000). &quot;Ataxia telangiectasia-mutated phosphorylates Chk2 in vivo and in vitro.&quot; <u>PNAS</u> <b>97</b>(19): 10389-10394.<p>
Maya, R., M. Balass, et al. (2001). &quot;ATM-dependent phosphorylation of Mdm2 on serine 395: role in p53 activation by DNA damage.&quot; <u>Genes Dev.</u> <b>15</b>(9): 1067-1077.<p>
McCabe, M. T., J. N. Davis, et al. (2005). &quot;Regulation of DNA Methyltransferase 1 by the pRb/E2F1 Pathway.&quot; <u>Cancer Res</u> <b>65</b>(9): 3624-3632.<p>
Meloni, A. R., C.-H. Lai, et al. (2005). &quot;A Mechanism of COOH-Terminal Binding Protein-Mediated Repression.&quot; <u>Mol Cancer Res</u> <b>3</b>(10): 575-583.<p>
Miard, S. and L. Fajas (2005). &quot;Atypical transcriptional regulators and cofactors of PPAR[gamma].&quot; <u>Int J Obes Relat Metab Disord</u> <b>29</b>(S1): S10-S12.<p>
Minella, A. and B. Clurman (2005 ). &quot;Mechanisms of tumor suppression by the SCF(Fbw7).&quot; <u>Cell Cycle</u> <b>4</b>(10): 1356-9.<p>
Minella, A. C., M. Welcker, et al. (2005). &quot;Ras activity regulates cyclin E degradation by the Fbw7 pathway.&quot; <u>PNAS</u> <b>102</b>(27): 9649-9654.<p>
Morris, E. and N. Dyson (2001). &quot;Retinoblastoma protein partners.&quot; <u>Adv Cancer Res.</u> <b>82</b>: 1-54.<p>
Morris, L., K. E. Allen, et al. (2000). &quot;Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.&quot; <u>Nat Cell Biol</u> <b>2</b>(4): 232-239.<p>
Morris, M. C., C. Gondeau, et al. (2002). &quot;Kinetic Mechanism of Activation of the Cdk2/Cyclin A Complex. KEY ROLE OF THE C-LOBE OF THE Cdk.&quot; <u>J. Biol. Chem.</u> <b>277</b>(26): 23847-23853.<p>
Mousli, M., R. Hopfner, et al. (2003). &quot; ICBP90 belongs to a new family of proteins with an expression that is deregulated in cancer cells.&quot; <u>Br J Cancer</u> <b>89</b>(1): 120-7.<p>
Mu, X. and C. Chang (2003). &quot;TR3 Orphan Nuclear Receptor Mediates Apoptosis through Up-regulating E2F1 in Human Prostate Cancer LNCaP Cells.&quot; <u>J. Biol. Chem.</u> <b>278</b>(44): 42840-42845.<p>
Muchardt, C. and M. Yaniv (2001). &quot;When the SWI/SNF complex remodels...the cell cycle.&quot; <u>Oncogene</u> <b>20</b>(24): 3067-75.<p>
Muller, H., A. P. Bracken, et al. (2001). &quot;E2Fs regulate the expression of genes involved in differentiation, development, proliferation, and apoptosis.&quot; <u>Genes Dev.</u> <b>15</b>(3): 267-285.<p>
Muller-Weeks, S., R. J. Balzer, et al. (2005). &quot;Proliferation-dependent expression of nuclear uracil-DNA glycosylase is mediated in part by E2F-4.&quot; <u>DNA Repair</u> <b>4</b>(2): 183-190.<p>
Murray, A. and T. Hunt (1994).<u> The Cell Cycle: an introduction</u>, Oxford University Press.<p>
Nahle, Z., J. Polakoff, et al. (2002). &quot;Direct coupling of the cell cycle and cell death machinery by E2F.&quot; <u>Nat Cell Biol</u> <b>4</b>(11): 859-864.<p>
Nevins, J. R. (2001). &quot;The Rb/E2F pathway and cancer.&quot; <u>Hum. Mol. Genet.</u> <b>10</b>(7): 699-703.<p>
Nielsen, S. J., R. Schneider, et al. (2001). &quot;Rb targets histone H3 methylation and HP1 to promoters.&quot; <u>Nature</u> <b>412</b>(6846): 561-565.<p>
Nowak, K., K. Kerl, et al. (2006). &quot;BMI1 is a target gene of E2F-1 and is strongly expressed in primary neuroblastomas.&quot; <u>Nucleic Acids Res</u> <b>34</b>(6): 1745-54.<p>
Nowak, K., K. Killmer, et al. (2007). &quot;E2F-1 regulates expression of FOXO1 and FOXO3a.&quot; <u>Biochim Biophys Acta</u> <b>1769</b>(4): 244-52.<p>
Oberley, M. J., D. R. Inman, et al. (2003). &quot;E2F6 Negatively Regulates BRCA1 in Human Cancer Cells without Methylation of Histone H3 on Lysine 9.&quot; <u>J. Biol. Chem.</u> <b>278</b>(43): 42466-42476.<p>
Oda, K., T. Kimura, et al. (2004). &quot;Molecular Interaction Map of a Macrophage.&quot; <u>AFCS Research Reports</u> <b>2</b>.<p>
Oda, K. and H. Kitano (2006). &quot;A comprehensive map of the toll-like receptor signaling network.&quot; <u>Mol Syst Biol</u> <b>2</b>.<p>
Oda, K., Y. Matsuoka, et al. (2005). &quot;A comprehensive pathway map of epidermal growth factor receptor signaling.&quot; <u>Mol Syst Biol</u> <b>1</b>: E1-E17.<p>
Ogawa, H., K.-i. Ishiguro, et al. (2002). &quot;A Complex with Chromatin Modifiers That Occupies E2F- and Myc-Responsive Genes in G0 Cells.&quot; <u>Science</u> <b>296</b>(5570): 1132-1136.<p>
Ohtani, K., J. DeGregori, et al. (1995). &quot;Regulation of the Cyclin E Gene by Transcription Factor E2F1.&quot; <u>PNAS</u> <b>92</b>(26): 12146-12150.<p>
Ohtani, N., K. Yamakoshi, et al. (2004). &quot;The p16INK4a-RB pathway: molecular link between cellular senescence and tumor suppression.&quot; <u>J Med Invest. </u><b>51</b>(3-4): 146-53.<p>
Orend, G., T. Hunter, et al. (1998). &quot;Cytoplasmic displacement of cyclin E-cdk2 inhibitors p21Cip1 and p27Kip1 in anchorage-independent cells.&quot; <u>Oncogene</u> <b>16</b>(20): 2575-83.<p>
Ortega, S., M. Malumbres, et al. (2002). &quot;Cyclin D-dependent kinases, INK4 inhibitors and cancer.&quot; <u>Biochimica et Biophysica Acta (BBA) - Reviews on Cancer</u> <b>1602</b>(1): 73-87.<p>
Parakati, R. and J. X. DiMario (2005). &quot;Dynamic Transcriptional Regulatory Complexes, Including E2F4, p107, p130, and Sp1, Control Fibroblast Growth Factor Receptor 1 Gene Expression during Myogenesis.&quot; <u>J. Biol. Chem.</u> <b>280</b>(22): 21284-21294.<p>
Parakati, R. and J. X. DiMario (2005). &quot;Repression of fibroblast growth factor receptor 1 gene expression by E2F4 in skeletal muscle cells.&quot; <u>Developmental Dynamics</u> <b>232</b>(1): 119-130.<p>
Parise, P., G. Finocchiaro, et al. (2006). &quot;Lap2alpha expression is controlled by E2F and deregulated in various human tumors.&quot; <u>Cell Cycle</u> <b>5</b>(12): 1331-41.<p>
Parisi, T., A. Pollice, et al. (2002). &quot;Transcriptional Regulation of the Human Tumor Suppressor p14ARF by E2F1, E2F2, E2F3, and Sp1-like Factors.&quot; <u>Biochemical and Biophysical Research Communications</u> <b>291</b>(5): 1138-1145.<p>
Parker, L. L. and H. Piwnica-Worms (1992). &quot;Inactivation of the p34cdc2-cyclin B complex by the human WEE1 tyrosine kinase.&quot; <u>Science</u> <b>257</b>(5078): 1955-1957.<p>
Parker, L. L., S. A. Walter, et al. (1993). &quot;Phosphorylation and inactivation of the mitotic inhibitor Weel by the nim1/cdr1 kinase.&quot; <u>Nature</u> <b>363</b>(6431): 736-738.<p>
Pediconi, N., A. Ianari, et al. (2003). &quot;Differential regulation of E2F1 apoptotic target genes in response to DNA damage.&quot; <u>Nat Cell Biol</u> <b>5</b>(6): 552-558.<p>
Peng, C.-Y., P. R. Graves, et al. (1997). &quot;Mitotic and G2 Checkpoint Control: Regulation of 14-3-3?Protein Binding by Phosphorylation of Cdc25C on Serine-216.&quot; <u>Science</u> <b>277</b>(5331): 1501-1505.<p>
Phillips, A. C., M. K. Ernst, et al. (1999). &quot;E2F-1 Potentiates Cell Death by Blocking Antiapoptotic Signaling Pathways.&quot; <u>Molecular Cell</u> <b>4</b>(5): 771-781.<p>
Pines, J. and T. Hunter (1991). &quot;Human cyclins A and B1 are differentially located in the cell and undergo cell cycle-dependent nuclear transport.&quot; <u>J. Cell Biol.</u> <b>115</b>(1): 1-17.<p>
Pines, J. and T. Hunter (1994). &quot;The differential localization of human cyclins A and B is due to a cytoplasmic retention signal in cyclin B.&quot; <u>EMBO J. </u><b>13</b>(16): 3772-81.<p>
Planas-Silva, M. D. and R. A. Weinberg (1997). &quot;The restriction point and control of cell proliferation.&quot; <u>Current Opinion in Cell Biology</u> <b>9</b>(6): 768-772.<p>
Plessner, H. L., P. L. Lin, et al. (2007). &quot;Neutralization of Tumor Necrosis Factor (TNF) by Antibody but not TNF Receptor Fusion Molecule Exacerbates Chronic Murine Tuberculosis.&quot; <u>J Infect Dis</u> <b>195</b>(11): 1643-50.<p>
Pohlers, M., M. Truss, et al. (2005). &quot;A Role for E2F6 in the Restriction of Male-Germ-Cell-Specific Gene Expression.&quot; <u>Current Biology</u> <b>15</b>(11): 1051-1057.<p>
Polager, S. and D. Ginsberg (2003). &quot;E2F Mediates Sustained G2 Arrest and Down-regulation of Stathmin and AIM-1 Expression in Response to Genotoxic Stress.&quot; <u>J. Biol. Chem.</u> <b>278</b>(3): 1443-1449.<p>
Polager, S., Y. Kalma, et al. ( 2002 ). &quot;E2Fs up-regulate expression of genes involved in DNA replication, DNA repair and mitosis.&quot; <u>Oncogene</u> <b>21</b>(3): 437-46.<p>
Powers, J. T., S. Hong, et al. (2004). &quot;E2F1 Uses the ATM Signaling Pathway to Induce p53 and Chk2 Phosphorylation and Apoptosis.&quot; <u>Mol Cancer Res</u> <b>2</b>(4): 203-214.<p>
Putowski, L., W. Gasior, et al. (2001). &quot;[Differences in human and rat FSH receptors promote activity as a result of the transcriptional factors: E2F1, E2F4 and E2F5 overexpression].&quot; <u>Ginekol Pol</u> <b>72</b>(12A): 1560-6.<p>
Rape, M. and M. W. Kirschner (2004). &quot;Autonomous regulation of the anaphase-promoting complex couples mitosis to S-phase entry.&quot; <u>Nature</u> <b>432</b>(7017): 588-595.<p>
Rayman, J. B., Y. Takahashi, et al. (2002). &quot;E2F mediates cell cycle-dependent transcriptional repression in vivo by recruitment of an HDAC1/mSin3B corepressor complex.&quot; <u>Genes Dev.</u> <b>16</b>(8): 933-947.<p>
Ren, B., H. Cam, et al. (2002). &quot;E2F integrates cell cycle progression with DNA repair, replication, and G2/M checkpoints.&quot; <u>Genes Dev.</u> <b>16</b>(2): 245-256.<p>
Ren, S. and B. J. Rollins (2004). &quot;Cyclin C/Cdk3 Promotes Rb-Dependent G0 Exit.&quot; <u>Cell</u> <b>117</b>(2): 239-251.<p>
Rogoff, H. A., M. T. Pickering, et al. (2004). &quot;Apoptosis Associated with Deregulated E2F Activity Is Dependent on E2F1 and Atm/Nbs1/Chk2.&quot; <u>Mol. Cell. Biol.</u> <b>24</b>(7): 2968-2977.<p>
Roussel, M. (1999). &quot;The INK4 family of cell cycle inhibitors in cancer.&quot; <u>Oncogene</u> <b>18</b>(38): 5311-7.<p>
Sage, J. (2004). &quot;Cyclin C Makes an Entry into the Cell Cycle.&quot; <u>Developmental Cell</u> <b>6</b>(5): 607-608.<p>
Sakchaisri, K., S. Asano, et al. (2004). &quot;Coupling morphogenesis to mitotic entry.&quot; <u>PNAS</u> <b>101</b>(12): 4124-4129.<p>
Sala, A., N. C. Nicolaides, et al. (1994). &quot;Correlation between E2F-1 Requirement in the S Phase and E2F-1 Transactivation of Cell Cycle-related Genes in Human Cells.&quot; <u>Cancer Res</u> <b>54</b>(6): 1402-1406.<p>
Salomoni, P. and P. P. Pandolfi (2002). &quot;The Role of PML in Tumor Suppression.&quot; <u>Cell</u> <b>108</b>(2): 165-170.<p>
Sanchez, I. and B. D. Dynlacht (2005). &quot;New insights into cyclins, CDKs, and cell cycle control.&quot; <u>Seminars in Cell &amp; Developmental Biology</u> <b>16</b>(3): 311-321.<p>
Sánchez-Beato, M., E. Sánchez, et al. (2004). &quot;Abnormal PcG protein expression in Hodgkin's lymphoma. Relation with E2F6 and NF?B transcription factors.&quot; <u>The Journal of Pathology</u> <b>204</b>(5): 528-537.<p>
Seelan, R. S., L. K. Parthasarathy, et al. (2004). &quot;E2F1 regulation of the human myo-inositol 1-phosphate synthase (ISYNA1) gene promoter.&quot; <u>Archives of Biochemistry and Biophysics</u> <b>431</b>(1): 95-106.<p>
Semizarov, D., P. Kroeger, et al. (2004). &quot;siRNA-mediated gene silencing: a global genome view.&quot; <u>Nucl. Acids Res.</u> <b>32</b>(13): 3836-3845.<p>
Serrano, M., G. J. Hannon, et al. (1993). &quot;A new regulatory motif in cell-cycle control causing specific inhibition of cyclin D/CDK4.&quot; <u>Nature</u> <b>366</b>(6456): 704-707.<p>
Shannon, P., A. Markiel, et al. (2003). &quot;Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction Networks.&quot; <u>Genome Res.</u> <b>13</b>(11): 2498-2504.<p>
Sherr, C. J. and F. McCormick (2002). &quot;The RB and p53 pathways in cancer.&quot; <u>Cancer Cell</u> <b>2</b>(2): 103-112.<p>
Sherr, C. J. and J. M. Roberts (1999). &quot;CDK inhibitors: positive and negative regulators of G1-phase progression.&quot; <u>Genes Dev.</u> <b>13</b>(12): 1501-1512.<p>
Slansky, J. E., Y. Li, et al. (1993). &quot;A protein synthesis-dependent increase in E2F1 mRNA correlates with growth regulation of the dihydrofolate reductase promoter.&quot; <u>Mol. Cell. Biol.</u> <b>13</b>(3): 1610-1618.<p>
Sorensen, C., R. Syljuasen, et al. (2004). &quot; ATR, Claspin and the Rad9-Rad1-Hus1 complex regulate Chk1 and Cdc25A in the absence of DNA damage.&quot; <u>Cell Cycle </u><b>3</b>(7): 941-5.<p>
Stanelle, J., T. Stiewe, et al. (2002). &quot;Gene expression changes in response to E2F1 activation.&quot; <u>Nucl. Acids Res.</u> <b>30</b>(8): 1859-1867.<p>
Stevaux, O. and N. J. Dyson (2002). &quot;A revised picture of the E2F transcriptional network and RB function.&quot; <u>Current Opinion in Cell Biology</u> <b>14</b>(6): 684-691.<p>
Stevens, C., L. Smith, et al. (2003). &quot;Chk2 activates E2F-1 in response to DNA damage.&quot; <u>Nat Cell Biol</u> <b>5</b>(5): 401-409.<p>
Stone, S., P. Jiang, et al. (1995). &quot;Complex Structure and Regulation of the P16 (MTS1) Locus.&quot; <u>Cancer Res</u> <b>55</b>(14): 2988-2994.<p>
Storre, J., H. Elsasser, et al. (2002). &quot;Homeotic transformations of the axial skeleton that accompany a targeted deletion of E2f6.&quot; <u>EMBO Rep.</u> <b>3</b>(7): 695-700.<p>
Strausfeld, U., A. Fernandez, et al. (1994). &quot;Activation of p34cdc2 protein kinase by microinjection of human cdc25C into mammalian cells. Requirement for prior phosphorylation of cdc25C by p34cdc2 on sites phosphorylated at mitosis.&quot; <u>J. Biol. Chem.</u> <b>269</b>(8): 5989-6000.<p>
Strausfeld, U., J. C. Labbe, et al. (1991). &quot;Dephosphorylation and activation of a p34cdc2/cyclin B complex in vitro by human CDC25 protein.&quot; <u>Nature</u> <b>351</b>(6323): 242-245.<p>
Strieder, V. and W. Lutz (2003). &quot;E2F Proteins Regulate MYCN Expression in Neuroblastomas.&quot; <u>J. Biol. Chem.</u> <b>278</b>(5): 2983-2989.<p>
Tabin, C. J. (1982). &quot;Mechanism of activation of a human oncogene.&quot; <u>Nature</u> <b>300</b>: 143-149.<p>
Takahashi, Y., J. B. Rayman, et al. (2000). &quot;Analysis of promoter binding by the E2F and pRB families in vivo: distinct E2F proteins mediate activation and repression.&quot; <u>Genes Dev.</u> <b>14</b>(7): 804-816.<p>
Takai, H., K. Tominaga, et al. (2000). &quot;Aberrant cell cycle checkpoint function and early embryonic death in Chk1-/- mice.&quot; <u>Genes Dev.</u> <b>14</b>(12): 1439-1447.<p>
Takizawa, C. G. and D. O. Morgan (2000). &quot;Control of mitosis by changes in the subcellular location of cyclin-B1-Cdk1 and Cdc25C.&quot; <u>Current Opinion in Cell Biology</u> <b>12</b>(6): 658-665.<p>
Tannapfel, A., F. Sommerer, et al. (2002). &quot;Genetic and epigenetic alterations of the INK4a-ARF pathway in cholangiocarcinoma.&quot; <u>The Journal of Pathology</u> <b>197</b>(5): 624-631.<p>
Tashiro, E., H. Maruki, et al. (2003). &quot;Overexpression of Cyclin D1 Contributes to Malignancy by Up-Regulation of Fibroblast Growth Factor Receptor 1 via the pRB/E2F Pathway.&quot; <u>Cancer Res</u> <b>63</b>(2): 424-431.<p>
Tashiro, E., Y. Minato, et al. (2003). &quot;Regulation of FGF receptor-2 expression by transcription factor E2F-1.&quot; <u>Oncogene</u> <b>22</b>(36): 5630-5.<p>
Taubert, S., C. Gorrini, et al. (2004). &quot;E2F-Dependent Histone Acetylation and Recruitment of the Tip60 Acetyltransferase Complex to Chromatin in Late G1.&quot; <u>Mol. Cell. Biol.</u> <b>24</b>(10): 4546-4556.<p>
Tedesco, D., J. Lukas, et al. (2002). &quot;The pRb-related protein p130 is regulated by phosphorylation-dependent proteolysis via the protein-ubiquitin ligase SCFSkp2.&quot; <u>Genes Dev.</u> <b>16</b>(22): 2946-2957.<p>
Thierry, F., M. A. Benotmane, et al. (2004). &quot;A Genomic Approach Reveals a Novel Mitotic Pathway in Papillomavirus Carcinogenesis.&quot; <u>Cancer Res</u> <b>64</b>(3): 895-903.<p>
Thomas, P. D., M. J. Campbell, et al. (2003). &quot;PANTHER: A Library of Protein Families and Subfamilies Indexed by Function.&quot; <u>Genome Res.</u> <b>13</b>(9): 2129-2141.<p>
Toyoshima-Morimoto, F., E. Taniguchi, et al. (2002). &quot;Plk1 promotes nuclear translocation of human Cdc25C during prophase.&quot; <u>EMBO Rep.</u> <b>3</b>(4): 341-8.<p>
Trimarchi, J. M., B. Fairchild, et al. (2001). &quot;The E2F6 transcription factor is a component of the mammalian Bmi1-containing polycomb complex.&quot; <u>PNAS</u> <b>98</b>(4): 1519-1524.<p>
Tsantoulis, P. K. and V. G. Gorgoulis (2005). &quot;Involvement of E2F transcription factor family in cancer.&quot; <u>European Journal of Cancer</u> <b>41</b>(16): 2403-2414.<p>
Tseng, Y.-H., A. J. Butte, et al. (2005). &quot;Prediction of preadipocyte differentiation by gene expression reveals role of insulin receptor substrates and necdin.&quot; <u>Nat Cell Biol</u> <b>7</b>(6): 601-611.<p>
Unoki, M., T. Nishidate, et al. (2004 ). &quot; ICBP90, an E2F-1 target, recruits HDAC1 and binds to methyl-CpG through its SRA domain.&quot; <u>Oncogene</u> <b>23</b>(46): 7601-10.<p>
Uto, K., D. Inoue, et al. (2004). &quot;Chk1, but not Chk2, inhibits Cdc25 phosphatases by a novel common mechanism.&quot; <u>EMBO J.</u> <b>23</b>(16): 3386-96.<p>
Vakoc, C. R., S. A. Mandat, et al. (2005). &quot;Histone H3 Lysine 9 Methylation and HP1[gamma] Are Associated with Transcription Elongation through Mammalian Chromatin.&quot; <u>Molecular Cell</u> <b>19</b>(3): 381-391.<p>
Valk-Lingbeek, M. E., S. W. M. Bruggeman, et al. (2004). &quot;Stem Cells and Cancer: The Polycomb Connection.&quot; <u>Cell</u> <b>118</b>(4): 409-418.<p>
Vandel, L., E. Nicolas, et al. (2001). &quot;Transcriptional Repression by the Retinoblastoma Protein through the Recruitment of a Histone Methyltransferase.&quot; <u>Mol. Cell. Biol.</u> <b>21</b>(19): 6484-6494.<p>
Verlinden, L., G. Eelen, et al. (2005). &quot;Characterization of the condensin component Cnap1 and protein kinase Melk as novel E2F target genes down-regulated by 1,25-dihydroxyvitamin D3.&quot; <u>J Biol Chem</u> <b>280</b>(45): 37319-30.<p>
Vermeulen, K., D. R. Van Bockstaele, et al. (2003). &quot;The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer.&quot; <u>Cell Proliferation</u> <b>36</b>(3): 131-149.<p>
Vernell, R., K. Helin, et al. (2003). &quot;Identification of Target Genes of the p16INK4A-pRB-E2F Pathway.&quot; <u>J. Biol. Chem.</u> <b>278</b>(46): 46124-46137.<p>
Verona, R., K. Moberg, et al. (1997). &quot;E2F activity is regulated by cell cycle-dependent changes in subcellular localization.&quot; <u>Mol. Cell. Biol.</u> <b>17</b>(12): 7268-7282.<p>
Viallard, J. F., F. Lacombe, et al. (2001). &quot;Mecanismes moleculaires controlant le cycle cellulaire : aspects fondamentaux et implications en cancerologieMolecular mechanisms controling the cell cycle: main considerations and implications in oncology.&quot; <u>Cancer/Radiotherapie</u> <b>5</b>(2): 109-129.<p>
Vidal, A. and A. Koff (2000). &quot;Cell-cycle inhibitors: three families united by a common cause.&quot; <u>Gene</u> <b>247</b>(1-2): 1-15.<p>
Vorburger, S., A. Pataer, et al. (2002). &quot;Role for the double-stranded RNA activated protein kinase PKR in E2F-1-induced apoptosis.&quot; <u>Oncogene</u> <b>21</b>(41): 6278-88.<p>
Vorburger, S. A., N. Hetrakul, et al. (2005). &quot;Gene therapy with E2F-1 up-regulates the protein kinase PKR and inhibits growth of leiomyosarcoma in vivo.&quot; <u>Mol Cancer Ther</u> <b>4</b>(11): 1710-1716.<p>
Wang, B., K. Liu, et al. (2004). &quot;A Role for 14-3-3{tau} in E2F1 Stabilization and DNA Damage-induced Apoptosis.&quot; <u>J. Biol. Chem.</u> <b>279</b>(52): 54140-54152.<p>
Wang, C., X. Hou, et al. (2005). &quot;Activation of p27Kip1 Expression by E2F1: A NEGATIVE FEEDBACK MECHANISM.&quot; <u>J. Biol. Chem.</u> <b>280</b>(13): 12339-12343.<p>
Wang, G.-L., P. Iakova, et al. (2004). &quot;Liver tumors escape negative control of proliferation via PI3K/Akt-mediated block of C/EBP{alpha} growth inhibitory activity.&quot; <u>Genes Dev.</u> <b>18</b>(8): 912-925.<p>
Wang, H., N. Shao, et al. (1997). &quot;BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.&quot; <u>Oncogene</u> <b>15</b>(2): 143-57.<p>
Watanabe, N., H. Arai, et al. (2004). &quot;M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF{beta}-TrCP.&quot; <u>PNAS</u> <b>101</b>(13): 4419-4424.<p>
Watanabe, N., H. Arai, et al. (2004). &quot;M-phase kinases induce phospho-dependent ubiquitination of somatic Wee1 by SCF{beta}-TrCP.&quot; <u>PNAS</u> <b>101</b>(13): 4419-4424.<p>
Weinberg, R. A. (1995). &quot;The retinoblastoma protein and cell cycle control.&quot; <u>Cell</u> <b>81</b>(3): 323-330.<p>
Weinmann, A. S., S. M. Bartley, et al. (2001). &quot;Use of Chromatin Immunoprecipitation To Clone Novel E2F Target Promoters.&quot; <u>Mol. Cell. Biol.</u> <b>21</b>(20): 6820-6832.<p>
Weinmann, A. S., P. S. Yan, et al. (2002). &quot;Isolating human transcription factor targets by coupling chromatin immunoprecipitation and CpG island microarray analysis.&quot; <u>Genes Dev.</u> <b>16</b>(2): 235-244.<p>
Wells, J., C. R. Graveel, et al. (2002). &quot;The identification of E2F1-specific target genes.&quot; <u>PNAS</u> <b>99</b>(6): 3890-3895.<p>
Williamson, E., G. Burgess, et al. (1997). &quot;Cyclic AMP negatively controls c-myc transcription and G1 cell cycle progression in p210 BCR-ABL transformed cells: inhibitory activity exerted through cyclin D1 and cdk4.&quot; <u>Leukemia</u> <b>11</b>(1): 73-85.<p>
Wolfe, B. and K. Gould (2004). &quot; Inactivating Cdc25, mitotic style.&quot; <u>Cell Cycle</u> <b>3</b>(5): 601-3.<p>
Won, J., J. Yim, et al. (2002). &quot;Opposing regulatory roles of E2F in human telomerase reverse transcriptase (hTERT) gene expression in human tumor and normal somatic cells.&quot; <u>FASEB J.</u>: 02-0311fje.<p>
Won, K. and S. Reed (1996). &quot;Activation of cyclin E/CDK2 is coupled to site-specific autophosphorylation and ubiquitin-dependent degradation of cyclin E.&quot; <u>EMBO J.</u> <b>15</b>(16): 4182-93.<p>
Woods, K., J. M. Thomson, et al. (2007). &quot;Direct regulation of an oncogenic micro-RNA cluster by E2F transcription factors.&quot; <u>J Biol Chem</u> <b>282</b>(4): 2130-4.<p>
Wu, J., Y. J. Jin, et al. (2007). &quot;PAC1 is a direct transcription target of E2F-1 in apoptotic signaling.&quot; <u>Oncogene</u>.<p>
Yamada, M., N. Sato, et al. (2002). &quot;A 63-Base Pair DNA Segment Containing an Sp1 Site but Not a Canonical E2F Site Can Confer Growth-dependent and E2F-mediated Transcriptional Stimulation of the Human ASK Gene Encoding the Regulatory Subunit for Human Cdc7-related Kinase.&quot; <u>J. Biol. Chem.</u> <b>277</b>(31): 27668-27681.<p>
Yang, J., E. S. G. Bardes, et al. (1998). &quot;Control of Cyclin B1 localization through regulated binding of the nuclear export factor CRM1.&quot; <u>Genes Dev.</u> <b>12</b>(14): 2131-2143.<p>
Yoshida, K. and I. Inoue (2004). &quot;Expression of MCM10 and TopBP1 is regulated by cell proliferation and UV irradiation via the E2F transcription factor.&quot; <u>Oncogene</u> <b>23</b>(37): 6250-60.<p>
Yoshida, K. and I. Inoue (2004). &quot;Regulation of Geminin and Cdt1 expression by E2F transcription factors.&quot; <u>Oncogene</u> <b>23</b>(21): 3802-12.<p>
Yu, Z.-K., J. L. M. Gervais, et al. (1998). &quot;Human CUL-1 associates with the SKP1/SKP2 complex and regulates p21CIP1/WAF1 and cyclin D proteins.&quot; <u>PNAS</u> <b>95</b>(19): 11324-11329.<p>
Zhang, H. S., M. Gavin, et al. (2000). &quot;Exit from G1 and S Phase of the Cell Cycle Is Regulated by Repressor Complexes Containing HDAC-Rb-hSWI/SNF and Rb-hSWI/SNF.&quot; <u>Cell</u> <b>101</b>(1): 79-89.<p>
Zhang, L. and C. Wang (2006). &quot;F-box protein Skp2: a novel transcriptional target of E2F.&quot; <u>Oncogene</u> <b>25</b>(18): 2615-27.<p>
Zhang, Y. and S. Chellappan (1995). &quot;Cloning and characterization of human DP2, a novel dimerization partner of E2F.&quot; <u>Oncogene</u> <b>10</b>(11): 2085-93.<p>
Zhao, H. and H. Piwnica-Worms (2001). &quot;ATR-Mediated Checkpoint Pathways Regulate Phosphorylation and Activation of Human Chk1.&quot; <u>Mol. Cell. Biol.</u> <b>21</b>(13): 4129-4139.<p>
Zhou, B. P., Y. Liao, et al. (2001). &quot;Cytoplasmic localization of p21Cip1/WAF1 by Akt-induced phosphorylation in HER-2/neu-overexpressing cells.&quot; <u>Nat Cell Biol</u> <b>3</b>(3): 245-252.<p>
Zhou, D., S. Masri, et al. (2005). &quot;Transcriptional regulation of the mouse PNRC2 promoter by the nuclear factor Y (NFY) and E2F1.&quot; <u>Gene</u> <b>361</b>: 89-100.<p>
Zhu, W., P. Giangrande, et al. (2004). &quot;E2Fs link the control of G1/S and G2/M transcription.&quot; <u>EMBO J. </u><b>23</b>(23): 4615-26.<p>
Ziebold, U., T. Reza, et al. (2001). &quot;E2F3 contributes both to the inappropriate proliferation and to the apoptosis arising in Rb mutant embryos.&quot; <u>Genes Dev.</u> <b>15</b>(4): 386-391.<p>
</body>
</html>
